Log in to save to my catalogue

In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards CO...

In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards CO...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7060591dc7e34acbba559fc8d8e31589

In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19

About this item

Full title

In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-05, Vol.12 (1), p.7798-7798, Article 7798

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Being the second major cause of death worldwide, lung cancer poses a significant threat to the health of patients. This worsened during the era of pandemic since lung cancer is found to be more prone to SARS-CoV-2 infection. Many recent studies imply a high frequency of COVID-19 infection associated severe outcome. However, molecular studies are st...

Alternative Titles

Full title

In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7060591dc7e34acbba559fc8d8e31589

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7060591dc7e34acbba559fc8d8e31589

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-11805-5

How to access this item